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ABSTRACT
The major role of sebaceous glands in mammals is to produce sebum, which coats the epidermis
and the hair providing waterprooﬁng, thermoregulation and photoprotection. However, as the
need for these functions decreased along the evolutionary changes in humans, a relevant question
has been raised: are sebaceous glands and sebum the remnants of our mammalian heritage or do
they have overtaken a far more complex role in human skin biology? Trying to provide answers
to this question, this review introduces the evolving ﬁeld of sebaceous immunobiology and puts
into the focus the pathways that sebum lipids use to inﬂuence the immune milieu of the skin. By
introducing possible modiﬁers of sebaceous lipogenesis and discussing the – human-speciﬁc –
alterations in composition and amount of sebum, the attribute of sebum as a sensitive tool, which is
capable of translating multiple signalling pathways into the dermal micro environment is
presented. Further their interaction with macrophages and keratinocytes involves sebum lipid
fractions into disease pathogenesis, which could lead – on the other side – to the development of
novel sebum-based therapeutic strategies.
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Lipid composition of human sebum
Sebocytes undergo a maturation process followed by a
cell type speciﬁc cell death. This procedure results in
the holocrine secretion of a composite substance called
sebum.1,2 Sebum is primarily composed of cell debris
and nonpolar (neutral) lipids, namely triglycerides,
wax esters, squalene, cholesterol and free fatty acids.3,4
Notably the sebum composition is species-speciﬁc,
human sebum is dominantly made up of triglycerides
and fatty acids adding up to 57.5% of total lipids,
followed by wax esters (26%), squalene (12%) and
cholesterol (4.5%).5
While some sebum lipid fractions are unique prod-
ucts of the human sebaceous gland, others are also
synthetized elsewhere in the body. Such example for
the latter is squalene, an unsaturated hydrocarbon,
which is a precursor of cholesterol. While in other tis-
sues squalene is rapidly converted to cholesterol, in
human sebocytes squalene is highly accumulated in
the produced sebum. Due to its prominent lubricant
and penetration efﬁciency squalene is capable of neu-
tralizing the formation of UV irradiation-induced
reactive oxygen species in the skin.6,7 On the other
hand, peroxidated squalene along with unsaturated
free fatty acids (FFA), has been reported to be come-
dogenic and therefore responsible for pathological
skin conditions.8,9
Linoleic (18:2, D9,12), an v6 polyunsaturated com-
pound, and a-linolenic acid (18:3, D9,12,15), an v3
polyunsaturated compound, are essential fatty acids.10
Ge et al. identiﬁed stearoyl-CoA D-6 desaturase as the
major fatty acid desaturase in human sebaceous
glands, which induces rapid oxidation and degrada-
tion of linoleic acid and its derivatives in sebaceous
gland cells.11
Due to the rapid degradation of linoleic acid in the
sebaceous cells, stearoyl-CoA D-6 desaturase is able to
convert palmitic acid (C16:0) into sapienic acid
(C16:1D6).3 Sapienic acid is a unique sebaceous
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monounsaturated fatty acid with a single double bond
at the sixth position.12,13 The elongation and further
desaturation of sapienic acid yields another unique
sebaceous gland fatty acid, sebaleic acid (18:2D5, 8).3
Sapienic acid exerts strong antibacterial and antifungal
activities.14 Remarkably, dietary palmitic acid directly
activates Toll-like receptor (TLR)-2 in mouse mono-
cytes15 and activates both the NLRP3 inﬂammasome
and mTORC116,17, however, it provides direct antibac-
terial activities against Propionibacterium acnes
(P. acnes) and enhances the skin innate antibacterial
defence by inducing the expression of human b-defen-
sin-2 (hBD2) in human sebocytes and mouse skin.18
Similarly to sapienic acid, oleic acid (18:1D9), a
major v9 monounsaturated fatty acid of sebum trigly-
cerides, exerts the strongest antibacterial and anti-
inﬂammatory properties among sebaceous fatty acids
and strongly enhances the innate antibacterial defence
of the skin.18,19
Sebum lipids in the dermis
The key question, whether sebum lipids could also
contribute to the dermal lipid content has been unan-
swered for more than 70 years.20 Butcher has proven
that sebaceous lipids, such as stearic (C18:0), oleic and
linoleic acids can penetrate through the follicle and,
moreover, accumulate around the sebaceous gland in
high concentrations.21,22 Extending these studies, we
measured the transepidermal penetration of ex vivo
topically applied lipids (linoleic, stearic, oleic, palmitic
acids and squalene) into the dermis using skin grafts
from hair and sebaceous gland poor regions with
Raman spectroscopy. We convincingly showed that
each of the tested lipids could readily penetrate
through the epidermis into the dermis.22
Moreover, lipid staining with Oil Red further con-
ﬁrmed prominent differences in the lipid content of
sebaceous gland-rich vs sebaceous gland-poor skin
samples.23 Visualizing the diffuse accumulation
throughout the upper part of the dermis in the seba-
ceous gland-rich skin further supports the concept
that sebum lipids should be accounted to have a role
not only in the vicinity of the sebaceous glands but
also in the homeostasis of the entire dermis. This sug-
gests a far more complex physiological role of sebum
and sebaceous glands, than that considered until
recently, and lay ground for further studies to also
investigate their effects on various cell types.
Sebum alterations in various skin diseases
Variations in the composition and amount of sebum
in different skin diseases have been detected,
which are suggested to not be simply disease markers
but may also play a signiﬁcant role in disease
pathogenesis.
Acne
In the recent years numerous studies have showed,
that in addition to an elevated sebum production,
acne patients have a markedly altered sebum composi-
tion.24,25 An altered ratio between saturated and
unsaturated fatty acids has been identiﬁed, and partic-
ularly, an increase in the C16:0/C16:1 nutrition lipid
ratio has been shown to improve acne, accompanied
by diminishing levels of linoleic acid content.24,26
These data imply that desaturation of fatty acids may
drive towards acne development.
Another interesting aspect of the detected changes
is the accumulation of lipid peroxides, speciﬁcally
squalene peroxide, which activates the Peroxisome
Proliferator Activated Receptors (PPARs), stimulate
keratinocyte proliferation and lipoxygenase (LOX)
activity, overall increasing the expression and secre-
tion of proinﬂammatory cytokines in acne.27-29
Furthermore, studies also detected decreased level
of vitamin E in acne subjects, which also leads to
inﬂammation and underlines a general importance of
lipid peroxidation in the development of acne.3
Seborrheic dermatitis
In relation to seborrheic dermatitis, studies suggest
that the lipases and phosphatases produced by Malas-
sezia hydrolyse sebaceous lipids, resulting in decreased
triglycerides and a corresponding increase in FFA,
which may cause irritation.30 Therefore, individual
sensitivity to the irritating FFA determines the conse-
quent inﬂammatory response and may deﬁne suscep-
tibility for seborrheic dermatitis.31
Rosacea
Despite the occurrence of rosacea in the sebaceous
gland-rich areas of the body, the amount of sebum
excretion does interestingly not show alterations in
rosacea patients compared to healthy controls.
However, there are changes in the overall relative
composition of sebum.32,33 Affected individuals
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exhibit elevated levels of myristic acid (C14:0) and
reduced levels of saturated long chain fatty acids.33
These lipids have a role in maintaining the skin barrier
integrity, therefore it is reasonable to assume that the
altered sebaceous fatty acid proﬁle is an important
contributor to skin barrier dysfunction leading to
rosacea.33
Psoriasis
Psoriatic lesions are usually characterized by various
degrees of sebaceous gland atrophy, however there has
been no correlation found between sebaceous gland
size and either total Psoriasis Area Severity Index
(PASI) or with the degree of erythema and inﬂamma-
tory inﬁltration.34 Despite having sebaceous gland
atrophy, the total amount of sebum production in
psoriatic skin is not signiﬁcantly changed.35 However,
an increase in the levels of phospholipids, triacylgly-
cerols, and cholesterol were found in the epidermis of
psoriatic patients, which correlated with the severity
of psoriasis.36–38
Atopic Dermatitis (AD)
Although AD is mainly characterized by the dysfunc-
tional synthesis of ceramides in keratinocytes39, AD
patients seem to exert a severely reduced sebum pro-
duction, which should contribute to diminished skin
hydration. However, and despite the fact that the pro-
portion of sebaceous lipids in the casual lipids is
decreased and epidermal lipids (e.g. cholesterol) are
increased, the total casual lipid amount is barely
changed (own unpublished data). Therefore, a link
between an altered sebaceous gland function and skin
barrier dysfunction seem to contribute to the develop-
ment of the disease, although the exact mechanisms
have not been elucidated.40,41
Immune functions of sebum lipids
Although, sebocytes are able to alter their sebum pro-
duction in response to different inﬂammatory stim-
uli42-45, research has mostly focused so far on
identifying a possible role of the co-produced proteins.
Studies of the last two decades delivered important
data; sebocytes have been shown to exert inﬂamma-
tory properties with the production of antimicrobial
peptides, cytokines and chemokines24, in which the
activation of TLR-2 and -4, shown to also be expressed
in sebocytes, play a crucial role.46-48 Furthermore,
sebocytes have also been identiﬁed as sources of vari-
ous adipokines, such as adiponectin, interleukin (IL)-
6, leptin, serpin E1, resistin and visfatin, within the
skin, highlighting that sebaceous glands could repre-
sent a link between inﬂammation and lipid metabo-
lism similarly to adipocytes.42,49 However, it is still
unknown how sebum lipids could contribute to the
inﬂammatory milieu of the skin, despite previous ﬁnd-
ings that free fatty acids may exert pro-inﬂammatory
effects.50
Modulation of the microbiome
Sebaceous glands secrete acids that form the acid
mantle, a ﬁne, slightly acidic (between pH 4.5 and pH
6.0) ﬁlm on the surface of the skin that provides a bar-
rier against pathogens, such as bacteria and viruses
that might penetrate the skin and are primarily of
alkaline nature.51 Moreover, sebaceous lipids make an
important contribution in maintaining the integrity of
the skin barrier along with lipids of epidermal ori-
gin2,52 thus contributing to the body’s ﬁrst line of
defence.53
The healthy human skin is populated with a
characteristic microbiome.54 Interestingly, its diver-
sity was found to be associated with the differences
in the quantitative levels of sebum and hydration
even between various parts of the face.55 One of
the most studied colonizing member is P. acnes, an
anaerobic bacterium, which is capable of metaboliz-
ing sebaceous triglycerides into FFA on the surface
of the skin via its lipases and peroxidases.56,57 This
bacterial lipase activity not only leads to an
increased presence of FFA on the surface of the
skin, but also to an altered sebum composition.58
Squalene in particular has been proposed as the
precursor of highly toxic proinﬂammatory media-
tors, produced by bacterial lipoperoxidase activity.59
These changes lead to hyperkeratinisation and
chronic inﬂammation, which further increases the
pathological microbial colonization of the skin,
thus sustaining acne formation.
Sebum may also act as a delivery system for antioxi-
dants and antimicrobial peptides. Such molecules with
antimicrobial properties are cathelicidin, psoriasin,
dermcidin and human hBD-2.60-62 As previously
described, Nakatsuji et al. found that linoleic, palmitic
and oleic acid, typically found in human sebum
DERMATO-ENDOCRINOLOGY e1375636-3
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enhanced the hBD-2 expression and antimicrobial
activity of human sebocytes against P. acnes.18
Other studies have showed that lauric and sapienic
acid as well as long-chain bases (sphingosine, dihy-
drosphingosine and 6-hydroxysphingosine) have
broad-acting antimicrobial properties.63 These antimi-
crobials act as part of the innate immune system of
the skin, and are generated through the action of
ceramidases from the stratum corneum.63
Immunoregulatory effect on macrophages
To address how sebum lipids and their possible
inﬂammatory role could be placed into the setting of
skin (patho)physiology at a cellular level, the interac-
tion between sebum component lipids and macro-
phages has been investigated in a current study. The
sebum lipids linoleic and oleic acid were detected to
be potent inducers of the so-called alternative macro-
phage activation, which is the characteristic activation
pathway for macrophages involved in tissue homeo-
stasis and repair functions.64 Furthermore, these lipids
also enhanced the ability of macrophages to phagocy-
tose different particles as well as P. acnes bacteria.23
Importantly, fatty acids exhibited a differential effect
on the inﬂammatory response of P. acnes-activated
macrophages.23 These results shed light on how
sebum composition plays a key role in regulating
immune responses against bacteria, such as P. acnes,
proving that sebum lipids not only can regulate
macrophage function, but also integrate into disease-
speciﬁc settings, such as acne.25 These results
undoubtedly set the basis for further considerations
on how macrophages and most likely other cell types
of the skin could be possible targets for the altered
sebum production not just in acne but also in other
dermatological diseases.
Interaction with keratinocytes
Keratinocytes have a signiﬁcant lipid production and
metabolism pivotal in the formation of the epidermal
lipid barrier, which made sebum lipids to be over-
looked for long time in understanding epidermal
integrity and functions. To ﬁnd a possible link
between sebum lipids and keratinocytes, the observed
prominent differences in the keratinocyte expression
of thymic stromal lymphopoietin (TSLP), one of the
major epimmunomes (epithelial cell-derived mole-
cules that can instruct immune cells), between
sebaceous gland-rich and -poor skin have been
addressed. When keratinocytes were cultured in the
presence of sebocyte supernatant, which contained all
sebocyte-derived lipids65, the expression of TSLP
mRNA increased. Searching for the lipid(s) behind
the induction, we found linoleic acid to increase TSLP
mRNA levels in a dose-dependent manner.66 These
data put forward the possibility that lipids not only of
epidermal but also of sebaceous origin could contrib-
ute to a sensitive homeostasis that highly inﬂuences
skin barrier functionality.
Signalling pathways affecting sebum
lipid composition
Sebaceous lipogenesis is controlled by a network of
processes. One of the major factors in humans are the
hormonal changes taking place at puberty.67 Seba-
ceous glands not only respond to androgens, but are
also capable of producing them. A prominent andro-
gen is 5a-dihydrotestosterone (5a-DHT), as sebocytes
are able to convert testosterone to 5a-DHT with the
enzyme 5a-reductase type I68. Both testosterone and
5a-DHT increase sebaceous proliferation, however,
they do not affect lipid synthesis.68,69
Studies revealed that for the androgenic inﬂuence
co-factors are also required, like members of the
nuclear receptor family, which by directly binding to
speciﬁc DNA sequences can regulate the expression of
their target genes upon activation with their ligands.70
PPARs with all three isoforms namely PPAR-a, -d,
-g1 and -g2 which are all expressed in sebocytes47, are
the prime members71 with varying effects on sebocyte
proliferation and lipogenesis.72 Previous studies
showed that linoleic and arachidonic acid activation
of PPAR-d and PPAR-g has led to an increased intra-
cellular lipid content of sebocytes, while PPAR-a ago-
nists blocked lipogenesis via inhibiting the leukotriene
pathway. Furthermore, PPAR-a seems to be related to
b-oxidation of fatty acids and lipid catabolism.73
Interestingly, P. acnes and its soluble factors may also
participate in the augmentation of sebaceous lipogene-
sis by increasing the production of the 15-deoxy-
D12,14-prostaglandin J2 (15d-PGJ2), an endogenous
activator of PPARg.74
The Liver X Receptor (LXR) receptors which have a
well-deﬁned role in cellular cholesterol homeostasis and
lipid metabolism75,76, also belong to the nuclear recep-
tors. Using LXR ligands such as 22R-hydroxycholesterol
e1375636-4 M. LOVASZI ET AL.
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an increase in the expression of key fatty acid synthetases
as well as sterol regulatory element-binding protein-1
(SREBP-1) was observed, followed by the accumulation
of lipid droplets, a hallmark of sebaceous lipogenesis.77,78
Retinoids also direct control sebaceous gland prolif-
eration and lipogenesis.79,80 Both retinoic acid
receptors (RAR-a and -g) and retinoid X receptors
(RXR-a, -b, -g) are expressed in human sebocytes and
their ligands all-trans retinoic acid (atRA) and 9-cis-
retinoic acid (9cRA) inhibit sebocyte differentiation
and lipid synthesis.80
Although often disregarded, the role of diet should
also be taken into account in order to understand seba-
ceous lipogenesis. A widely accepted mechanism is that
a diet rich in carbohydrates increases the activity of the
insulin-like growth factor 1 (IGF-1) pathways.81-83 The
presence of the IGF-1 receptor in sebocytes has been
described and was shown to activate the PI3K/ Akt/
FoxO1 pathway thus providing evidence that FoxO1
may be a key factor in the regulation of growth-factor
stimulatory effects on sebaceous lipogenesis and inﬂam-
mation in response to elevated IGF-1 and insulin lev-
els.84 Moreover, we have demonstrated that leptin “the
satiety hormone”, besides inducing the expression of
inﬂammatory cytokines such as IL-6 and IL-8 in sebo-
cytes also affects lipogenesis by increasing triglyceride
levels, thus increasing the ratio of monounsaturated
fatty acids or polyunsaturated fatty acids to saturated
fatty acids and by decreasing the levels of vitamin E,
which altogether are also the characteristics for acne
patients’ sebum.24,25,44
At last, neuropeptides are also known as factors
that enhance sebaceous lipogenesis. Corticotropin-
releasing hormone is expressed in human sebocytes
and augments the synthesis of sebaceous lipids in
vitro.85,79 Moreover, adrenocorticotropic hormone
and a-melanocyte-stimulating hormone have been
shown to increase squalene synthesis in primary
human sebocytes.86 Human sebocytes also express
melanocortin 5 receptor (MC5R), which is involved in
sebocyte differentiation and lipogenesis.87,88
Therapeutic perspectives in modulating
sebum composition
The observations of altered sebum composition made
so far in various skin diseases puts forward the ques-
tion of possible therapeutical solutions through
Figure 1. Sebum lipids orchestrate sebaceous-immunobiology. Sebum production and composition is regulated by intrinsic (i.e. PPAR,
LXR, RAR, RXR, endocannabinoids) and extrinsic (i.e. androgens, IGF1, insulin, leptin) factors. Sebum lipids (marked with red arrows) con-
tribute to the lipid barrier of the skin and penetrate through the epidermis to the dermis, however a direct diffusion from the sebaceous
glands has been proposed as well. Sebum fraction lipids also have a role in modulating both keratinocyte as well as macrophage func-
tions by altering their gene and protein expression levels, which may be important in maintaining the physiological dermal immune
milieu. In the defence response against pathogens, sebum lipids have multiple functions: exert antimicrobial effects, induce the cytokine
expression of sebocytes and keratinocytes as well as modulate the macrophage – P. acnes interaction, which may have a central role not
just in the pathogenesis of acne but also in other diseases. Further identiﬁcation of how sebum lipids could alter the functions of other
cell types is also a promising ﬁeld for research with pathological and therapeutic relevance.
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modulation of sebum composition.25 New compounds
might be utilized as topical treatments in acne, such as
long-chain polyunsaturated fatty acids, which could
target P. acnes and treat infections, e.g. with Staphylo-
coccus aureus, due to their antimicrobial and anti-
inﬂammatory properties, thus providing an alternative
for antibiotics in acne treatment.89 Palmitic acid, oleic
acid, and lauric acid have been already proposed as
alternatives to antibiotic therapy in acne
vulgaris.18,19,89,90
Controlling lipid production not only can be bene-
ﬁcial for acne patients, where the overproduction of
sebum and its compositional imbalance represents the
main problem. Severe skin dryness as observed in AD
patients might be remedied by manipulation of sebum
production towards a normal composition via the
stimulation of androgen or PPAR receptors, which
could potentially repair the defective skin barrier.91
Furthermore, the activation of LXR by synthetic
ligands may have therapeutic relevance, which could
also augment lipid production along with exerting
anti-inﬂammatory effects.91
Novel compounds such as endocannabinoids may
also provide solutions to various sebaceous gland-
related diseases. Recently Bıro et al. provided evidence
that sebocytes express cannabinoid receptor-2, more
interestingly arachidonoyl ethanolamide/anandamide,
2-arachidonoyl glycerol are also present in sebocytes
and can induce lipid production and apoptosis.42
Endocannabinoids generally up-regulate the expres-
sion of genes involved in lipid synthesis, such as
PPAR transcription factors, thus cannabinoid recep-
tor-2 antagonists or agonists may be utilized in the
management of sebaceous gland disorders.42,92
Conclusion
With the improvement of sebaceous gland research
more and more receptors, transcriptional factors,
chemokines and cytokines have been recognized in
sebocytes both in vitro and in vivo, leading to a
better understanding and positioning of sebaceous
gland biology in the context of immune mediated
pathways. However, only in recent years did our
focus shift to the most prominent feature of seba-
ceous glands: sebum production. Sebaceous gland
lipids have been shown to exhibit pro-and anti-
inﬂammatory properties, attributed with antimicro-
bial qualities and most recently they have been
demonstrated to exert a modulating role on
immune cells (Fig. 1). Further research is required,
both in understanding sebocyte function and lipi-
domics, to provide useful data for therapeutic
advances in sebaceous gland-related skin diseases.
Therefore, placing (sebum) lipids in the centre of
research provides a vast and intriguing ﬁeld for
further studies to come.
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